[Excretion of 5-hydroxyindole-3-acetic and 5-methoxyindole-3-acetic acids in cancer patients].
T I Sergeeva, T I Raushenbakh, M O Shevchenko, V G Rybal'chenko
Index: Vopr. Onkol. 33(10) , 20-5, (1987)
Full Text: HTML
Abstract
Daily urinary excretion of 5-hydroxy-3-indoleacetic acid (5-HIAA) and 5-methoxyindole-3-acetic acid (5-MIAA) was studied by chromatography-mass-spectrometry in patients with cancer and healthy subjects. A considerable increase in urinary 5-MIAA-excretion was shown in patients with cancer of the stomach, rectum and lung. In some cases, a correlation was found between high urine levels of carcinogenic 5-MIAA and similarly high levels of 5-HIAA excretion with urine.
Related Compounds
Related Articles:
2005-10-01
[Gen. Comp. Endocrinol. 144(1) , 67-77, (2005)]
2003-01-01
[Neuro Endocrinol. Lett. 24(3-4) , 259-62, (2003)]
1996-02-01
[Gen. Comp. Endocrinol. 101(2) , 165-72, (1996)]
2003-02-01
[J. Biol. Rhythms 18(1) , 63-70, (2003)]
2007-07-01
[Bioorg. Med. Chem. 15 , 4595-600, (2007)]